Our preliminary investigations demonstrating OC’s ability to downregulate PAR-2 and TNF-α expression in CRC models [83] provide a strong mechanistic rationale to further explore its therapeutic potential in modulating key oncogenic signaling cascades. The gene discussed is F2RL1; the disease is colorectal carcinoma.